KFAS
BLFS icon

Keating Financial Advisory Services’s BioLife Solutions BLFS Stock Holding History

Keating Financial Advisory Services’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$875 Buy
31
+19
+158% +$444 ﹤0.01% 2211
2026
Q1 		$229 Buy
+12
New +$265 ﹤0.01% 2361

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Keating Financial Advisory Services's BLFS Position: Q2 2026 in Review

Keating Financial Advisory Services increased its BioLife Solutions (BLFS) stake by 158% in Q2 2026, buying an estimated $444 and bringing the position to 31 shares worth $875. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Keating Financial Advisory Services first reported a position in BLFS in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Keating Financial Advisory Services held 31 shares of BioLife Solutions worth $875 as of Q2 2026.
  • Keating Financial Advisory Services bought 19 BioLife Solutions shares in Q2 2026, an estimated $444.
  • BioLife Solutions made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2211 holding.
  • Keating Financial Advisory Services first reported a position in BioLife Solutions in Q1 2026 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.